Therapeutic Efficacy and Inhibitory Mechanism of Regorafenib Combined With Radiation in Colorectal Cancer

Conclusion: Regorafenib may enhance the anti-CRC efficacy of RT.

Source: In Vivo - November 3, 2020 Category: Research Authors: LIU, Y.-C., CHIANG, I.-T., CHUNG, J.-G., HSIEH, J.-H., CHIANG, C.-H., WENG, M.-C., HSU, F.-T., LEE, Y.-H., CHANG, C.-S., LIN, S.-S. Tags: Experimental Studies Source Type: research